|
1
|
Pancreatic Cancer-National Cancer
Institute. U.S. National Institutes of Health. Cancer Gov.
http:www.cancer.gov/cancer-topics/types/pancreatic.
Accessed April 6, 2010
|
|
2
|
Maitra A and Hruban RH: Pancreatic cancer.
Annu Rev Pathol. 3:157–188. 2008. View Article : Google Scholar
|
|
3
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mulcahy MF, Wahl AO and Small W Jr: The
current status of combined radiotherapy and chemotherapy for
locally advanced or resected pancreas cancer. J Natl Compr Canc
Netw. 3:637–642. 2005.PubMed/NCBI
|
|
5
|
Pino SM, Xiong HQ, McConkey D and
Abbruzzese JL: Novel therapies for pancreatic adenocarcinoma. Curr
Oncol Rep. 6:199–206. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vaccaro V, Sperduti I and Milella M:
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N
Engl J Med. 365:768–769; author reply 769. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kerr JF, Winterford CM and Harmon BV:
Apoptosis. Its significance in cancer and cancer therapy. Cancer.
73:2013–2026. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dzubak P, Hajduch M, Vydra D, Hustova A,
Kvasnica M, Biedermann D, Markova L, Urban M and Sarek J:
Pharmacological activities of natural triterpenoids and their
therapeutic implications. Nat Prod Rep. 23:394–411. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang MT, Ho CT, Wang ZY, Ferraro T, Lou
YR, Stauber K, Ma W, Georgiadis C, Laskin JD and Conney AH:
Inhibition of skin tumorigenesis by rosemary and its constituents
carnosol and ursolic acid. Cancer Res. 54:701–708. 1994.PubMed/NCBI
|
|
10
|
Nishino H, Nishino A, Takayasu J, Hasegawa
T, Iwashima A, Hirabayashi K, Iwata S and Shibata S: Inhibition of
the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate
by some oleanane-type triterpenoid compounds. Cancer Res.
48:5210–5215. 1988.PubMed/NCBI
|
|
11
|
Ryu SY, Oak MH, Yoon SK, Cho DI, Yoo GS,
Kim TS and Kim KM: Anti-allergic and anti-inflammatory triterpenes
from the herb of Prunella vulgaris. Planta Med. 66:358–360. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Honda T, Rounds BV, Gribble GW, Suh N,
Wang Y and Sporn MB: Design and synthesis of
2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly
active inhibitor of nitric oxide production in mouse macrophages.
Bioorg Med Chem Lett. 8:2711–2714. 1998. View Article : Google Scholar
|
|
13
|
Suh N, Honda T, Finlay HJ, Barchowsky A,
Williams C, Benoit NE, Xie QW, Nathan C, Gribble GW and Sporn MB:
Novel triterpenoids suppress inducible nitric oxide synthase (iNOS)
and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer
Res. 58:717–723. 1998.PubMed/NCBI
|
|
14
|
Ito Y, Pandey P, Sporn MB, Datta R,
Kharbanda S and Kufe D: The novel triterpenoid CDDO induces
apoptosis and differentiation of human osteosarcoma cells by a
caspase-8 dependent mechanism. Mol Pharmacol. 59:1094–1099.
2001.PubMed/NCBI
|
|
15
|
Konopleva M, Tsao T, Estrov Z, Lee RM,
Wang RY, Jackson CE, McQueen T, Monaco G, Munsell M, Belmont J, et
al: The synthetic triterpenoid
2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces
caspase-dependent and -independent apoptosis in acute myelogenous
leukemia. Cancer Res. 64:7927–7935. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao X, Deeb D, Jiang H, Liu Y, Dulchavsky
SA and Gautam SC: Synthetic triterpenoids inhibit growth and induce
apoptosis in human glioblastoma and neuroblastoma cells through
inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling. J
Neurooncol. 84:147–157. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Konopleva M, Contractor R, Kurinna SM,
Chen W, Andreeff M and Ruvolo PP: The novel triterpenoid CDDO-Me
suppresses MAPK pathways and promotes p38 activation in acute
myeloid leukemia cells. Leukemia. 19:1350–1354. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shishodia S, Sethi G, Konopleva M,
Andreeff M and Aggarwal BB: A synthetic triterpenoid, CDDO-Me,
inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF
and chemotherapeutic agents through down-regulation of expression
of nuclear factor kappaB-regulated gene products in human leukemic
cells. Clin Cancer Res. 12:1828–1838. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chintharlapalli S, Papineni S, Konopleva
M, Andreef M, Samudio I and Safe S:
2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds
inhibit growth of colon cancer cells through peroxisome
proliferator-activated receptor gamma-dependent and -independent
pathways. Mol Pharmacol. 68:119–128. 2005.PubMed/NCBI
|
|
20
|
Liby K, Hock T, Yore MM, Suh N, Place AE,
Risingsong R, Williams CR, Royce DB, Honda T, Honda Y, et al: The
synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent
inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res.
65:4789–4798. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deeb D, Gao X, Jiang H, Dulchavsky SA and
Gautam SC: Oleanane triterpenoid CDDO-Me inhibits growth and
induces apoptosis in prostate cancer cells by independently
targeting prosurvival Akt and mTOR. Prostate. 69:851–860. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chin YW, Balunas MJ, Chai HB and Kinghorn
AD: Drug discovery from natural sources. AAPS J. 8:E239–E253. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Itokawa H, Morris-Natschke SL, Akiyama T
and Lee KH: Plant-derived natural product research aimed at new
drug discovery. J Nat Med. 62:263–280. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao X, Deeb D, Liu Y, Arbab AS, Divine GW,
Dulchavsky SA and Gautam SC: Prevention of prostate cancer with
oleanane synthetic triterpenoid CDDO-Me in the TRAMP mouse model of
prostate cancer. Cancers (Basel). 3:3353–3369. 2011. View Article : Google Scholar
|
|
25
|
Deeb D, Gao X, Liu Y, Jiang D, Divine GW,
Arbab AS, Dulchavsky SA and Gautam SC: Synthetic triterpenoid CDDO
prevents the progression and metastasis of prostate cancer in TRAMP
mice by inhibiting survival signaling. Carcinogenesis. 32:757–764.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ling X, Konopleva M, Zeng Z, Ruvolo V,
Stephens LC, Schober W, McQueen T, Dietrich M, Madden TL and
Andreeff M: The novel triterpenoid C-28 methyl ester of 2-cyano-3,
12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine
breast tumor growth through inactivation of STAT3 signaling. Cancer
Res. 67:4210–4218. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liby K, Royce DB, Williams CR, Risingsong
R, Yore MM, Honda T, Gribble GW, Dmitrovsky E, Sporn TA and Sporn
MB: The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl
amide prevent lung cancer induced by vinyl carbamate in A/J mice.
Cancer Res. 67:2414–2419. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Datta SR, Dudek H, Tao X, Masters S, Fu H,
Gotoh Y and Greenberg ME: Akt phosphorylation of BAD couples
survival signals to the cell-intrinsic death machinery. Cell.
91:231–241. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo
P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karin M, Cao Y, Greten FR and Li ZW:
NF-kappaB in cancer: From innocent bystander to major culprit. Nat
Rev Cancer. 2:301–310. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hay N and Sonenberg N: Upstream and
downstream of mTOR. Genes Dev. 18:1926–1945. 2004. View Article : Google Scholar : PubMed/NCBI
|
